121 related articles for article (PubMed ID: 31634191)
1. Cytomegalovirus-vectored vaccines for HIV and other pathogens.
Barry PA; Deere JD; Yue Y; Chang WWL; Schmidt KA; Wussow F; Chiuppesi F; Diamond DJ; Sparger EE; Walter MR; Hartigan-O'Connor DJ
AIDS; 2020 Mar; 34(3):335-349. PubMed ID: 31634191
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques.
Kaur A; Daniel MD; Hempel D; Lee-Parritz D; Hirsch MS; Johnson RP
J Virol; 1996 Nov; 70(11):7725-33. PubMed ID: 8892893
[TBL] [Abstract][Full Text] [Related]
3. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
[TBL] [Abstract][Full Text] [Related]
5. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
[TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus-vectored vaccines against HIV.
Abad-Fernandez M; Goonetilleke N
Curr Opin HIV AIDS; 2019 Mar; 14(2):137-142. PubMed ID: 30562176
[TBL] [Abstract][Full Text] [Related]
7. Utilizing a TLR5-Adjuvanted Cytomegalovirus as a Lentiviral Vaccine in the Nonhuman Primate Model for AIDS.
Deere JD; Chang WL; Castillo LD; Schmidt KA; Kieu HT; Renzette N; Kowalik T; Barthold SW; Shacklett BL; Barry PA; Sparger EE
PLoS One; 2016; 11(5):e0155629. PubMed ID: 27182601
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus mediates expansion of IL-15-responsive innate-memory cells with SIV killing function.
Méndez-Lagares G; Chin N; Chang WLW; Lee J; Rosás-Umbert M; Kieu HT; Merriam D; Lu W; Kim S; Adamson L; Brander C; Luciw PA; Barry PA; Hartigan-O'Connor DJ
J Clin Invest; 2021 Aug; 131(15):. PubMed ID: 34153005
[TBL] [Abstract][Full Text] [Related]
10. CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge.
Kwa S; Lai L; Gangadhara S; Siddiqui M; Pillai VB; Labranche C; Yu T; Moss B; Montefiori DC; Robinson HL; Kozlowski PA; Amara RR
J Virol; 2014 Sep; 88(17):9579-89. PubMed ID: 24920805
[TBL] [Abstract][Full Text] [Related]
11. RhCMV serostatus and vaccine adjuvant impact immunogenicity of RhCMV/SIV vaccines.
Chang WLW; Deere JD; Kieu HT; Castillo LD; Machmach K; Shen X; Tomaras GD; Shacklett BL; Barry PA; Hartigan-O'Connor DJ; Sparger EE
Sci Rep; 2020 Aug; 10(1):14056. PubMed ID: 32820216
[TBL] [Abstract][Full Text] [Related]
12. Novel vaccine vectors for HIV-1.
Barouch DH; Picker LJ
Nat Rev Microbiol; 2014 Nov; 12(11):765-71. PubMed ID: 25296195
[TBL] [Abstract][Full Text] [Related]
13. Decreased frequency of cytomegalovirus (CMV)-specific CD4+ T lymphocytes in simian immunodeficiency virus-infected rhesus macaques: inverse relationship with CMV viremia.
Kaur A; Hale CL; Noren B; Kassis N; Simon MA; Johnson RP
J Virol; 2002 Apr; 76(8):3646-58. PubMed ID: 11907204
[TBL] [Abstract][Full Text] [Related]
14. Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus Challenges.
Hessell AJ; Shapiro MB; Powell R; Malherbe DC; McBurney SP; Pandey S; Cheever T; Sutton WF; Kahl C; Park B; Zolla-Pazner S; Haigwood NL
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514914
[TBL] [Abstract][Full Text] [Related]
15. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.
Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132
[TBL] [Abstract][Full Text] [Related]
16. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251.
Buge SL; Murty L; Arora K; Kalyanaraman VS; Markham PD; Richardson ES; Aldrich K; Patterson LJ; Miller CJ; Cheng SM; Robert-Guroff M
J Virol; 1999 Sep; 73(9):7430-40. PubMed ID: 10438833
[TBL] [Abstract][Full Text] [Related]
18. Immunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaques.
Mörner A; Jansson M; Bunnik EM; Schøller J; Vaughan R; Wang Y; Montefiori DC; Otting N; Bontrop R; Bergmeier LA; Singh M; Wyatt RT; Schuitemaker H; Biberfeld G; Thorstensson R; Lehner T
J Virol; 2011 Jul; 85(13):6442-52. PubMed ID: 21490092
[TBL] [Abstract][Full Text] [Related]
19. Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: pathogenesis.
Sequar G; Britt WJ; Lakeman FD; Lockridge KM; Tarara RP; Canfield DR; Zhou SS; Gardner MB; Barry PA
J Virol; 2002 Aug; 76(15):7661-71. PubMed ID: 12097580
[TBL] [Abstract][Full Text] [Related]
20. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC
J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
